does semaglutide cause osteoporosis New studies have raised fresh alarms about the popular “weight-loss drug” Ozempic, revealing it may accelerate bone loss and weaken skeletal health in users. Research published in 2025–2026 shows patients on GLP-1 Drugs May Raise the

Discussion Although numerous studies have shown that cardiac energy metabolism is altered in pathological cardiac remodeling and that the resulting myocardial energy deficit can lead to further HF, there is minimal research on therapeutic targets and drugs based on this energy shift 2,38

Sources & References 1Healio (July 2026)

Semaglutide is a long-acting GLP-1 receptor agonist and one of the most referenced peptides in metabolic and incretin research

Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease

Figure 1 Publishers Note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

When CLA is taken as a supplement as part of a weight loss program, it helps the body break down fat more efficiently